Barclays Maintains Overweight on Sempra, Raises Price Target to $79
Portfolio Pulse from Benzinga Newsdesk
Barclays analyst Eric Beaumont has maintained an Overweight rating on Sempra (NYSE:SRE) and increased the price target from $77 to $79.
March 14, 2024 | 11:44 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Barclays has maintained an Overweight rating on Sempra and raised the price target from $77 to $79.
The upgrade in price target by a reputable analyst like Eric Beaumont from Barclays signals a positive outlook on Sempra's stock, likely leading to increased investor confidence and potentially a short-term increase in stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100